234 related articles for article (PubMed ID: 29570225)
1. Hidradenitis suppurativa in association with keratitis-ichthyosis-deafness syndrome treated with adalimumab.
Song YM; Kim YS; Lee JH; Park YM; Lee JY
J Dermatol; 2018 Sep; 45(9):e262-e263. PubMed ID: 29570225
[No Abstract] [Full Text] [Related]
2. Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?
Martina E; Campanati A; Giuliodori K; Offidani A
Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):21-23. PubMed ID: 28352932
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab.
Fattore D; Pistone G; Bongiorno MR
G Ital Dermatol Venereol; 2019 Apr; 154(2):218-220. PubMed ID: 29368847
[No Abstract] [Full Text] [Related]
4. Uncommon pretibial bilateral manifestation of Hidradenitis suppurativa (Hurley III) after discontinuation of systemic treatment with adalimumab: a serious reason to prefer surgery as a primary approach?
Tchernev G; Temelkova I; Wollina U
J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):e449-e451. PubMed ID: 31273867
[No Abstract] [Full Text] [Related]
5. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
Diamantova D; Lomickova I; Cetkovska P
Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa at the knees.
Gosnell HL; Sharghi K; Pickard C; Grider DJ
Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898405
[TBL] [Abstract][Full Text] [Related]
7. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab.
Caposiena Caro RD; Cannizzaro MV; Tartaglia C; Bianchi L
Clin Exp Dermatol; 2020 Jun; 45(4):438-444. PubMed ID: 31630436
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab (Humira
Gupta AK; Cernea M; Abramovits W; Vincent KD
Skinmed; 2016; 14(4):291-294. PubMed ID: 27784520
[No Abstract] [Full Text] [Related]
9. Steatocystoma multiplex suppurativa associated with hidradenitis suppurativa successfully treated with adalimumab.
Atzori L; Zanniello R; Pilloni L; Rongioletti F
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():42-44. PubMed ID: 31535759
[TBL] [Abstract][Full Text] [Related]
10. Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series.
Yen CF; Huang YH; Chi CC
Indian J Dermatol Venereol Leprol; 2021; 87(2):223-226. PubMed ID: 31389375
[TBL] [Abstract][Full Text] [Related]
11. Association and management of Crohn's disease plus hidradenitis suppurativa.
dos Santos CH; Netto PO; Kawaguchi KY; Parreira Alves JA; de Alencar Souza VP; Reverdito S
Inflamm Bowel Dis; 2012 Apr; 18(4):E801-2. PubMed ID: 21993924
[No Abstract] [Full Text] [Related]
12. A severe case of hidradenitis suppurativa with chronic anemia treated with adalimumab.
Arakawa H; Adachi T; Kobayashi Y; Inazumi T
J Dermatol; 2023 Jan; 50(1):e22-e23. PubMed ID: 36074661
[No Abstract] [Full Text] [Related]
13. A unique pneumopathy in a patient with skin nodules and abscesses.
Damiani G; di Meo N; Marzano AV
Intern Emerg Med; 2017 Aug; 12(5):637-640. PubMed ID: 28389858
[No Abstract] [Full Text] [Related]
14. A Genetic Variant in the BCL2 Gene Associates with Adalimumab Response in Hidradenitis Suppurativa Clinical Trials and Regulates Expression of BCL2.
Liu M; Degner J; Georgantas RW; Nader A; Mostafa NM; Teixeira HD; Williams DA; Kirsner RS; Nichols AJ; Davis JW; Waring JF
J Invest Dermatol; 2020 Mar; 140(3):574-582.e2. PubMed ID: 31465739
[TBL] [Abstract][Full Text] [Related]
15. Measuring treatment response to adalimumab in hidradenitis suppurativa patients: An observational study.
Kok Y; Nicolopoulos J; Braue A; Kern JS; Varigos G; Dolianitis C
Australas J Dermatol; 2020 Aug; 61(3):292-294. PubMed ID: 32065658
[No Abstract] [Full Text] [Related]
16. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
Kimball AB; Sobell JM; Zouboulis CC; Gu Y; Williams DA; Sundaram M; Teixeira HD; Jemec GB
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):989-94. PubMed ID: 26201313
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate.
Genovese G; Caorsi R; Moltrasio C; Marzano AV
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():40-41. PubMed ID: 31535768
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of hidradenitis suppurativa in the setting of Crohn disease with combination adalimumab and ustekinumab.
Cline A; Pichardo RO
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738849
[TBL] [Abstract][Full Text] [Related]
19. Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study.
Repetto F; Roccuzzo G; Burzi L; Mastorino L; Dapavo P; Quaglino P; Ribero S
Acta Derm Venereol; 2023 Apr; 103():adv5278. PubMed ID: 37073963
[No Abstract] [Full Text] [Related]
20. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
Harde V; Mrowietz U
J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
